[HTML][HTML] Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study
Background Previous studies have suggested that antithrombin may be beneficial for
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study.
T Tagami, H Matsui, Y Moroe, R Fukuda… - … of Intensive Care, 2017 - search.ebscohost.com
Background: Previous studies have suggested that antithrombin may be beneficial for
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
[PDF][PDF] Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study
T Tagami, H Matsui, Y Moroe, R Fukuda, A Shibata… - 2017 - cyberleninka.org
Background: Previous studies have suggested that antithrombin may be beneficial for
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
[PDF][PDF] Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study
T Tagami, H Matsui, Y Moroe, R Fukuda, A Shibata… - 2017 - core.ac.uk
Background: Previous studies have suggested that antithrombin may be beneficial for
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
[PDF][PDF] Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study
T Tagami, H Matsui, Y Moroe, R Fukuda, A Shibata… - 2017 - researchmap.jp
Background: Previous studies have suggested that antithrombin may be beneficial for
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study
T Tagami, H Matsui, Y Moroe, R Fukuda… - Annals of Intensive …, 2017 - infona.pl
Background Previous studies have suggested that antithrombin may be beneficial for
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study
T Tagami, H Matsui, Y Moroe… - … of intensive care, 2017 - pubmed.ncbi.nlm.nih.gov
Background Previous studies have suggested that antithrombin may be beneficial for
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
[HTML][HTML] Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study
T Tagami, H Matsui, Y Moroe, R Fukuda… - Annals of Intensive …, 2017 - ncbi.nlm.nih.gov
Background Previous studies have suggested that antithrombin may be beneficial for
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
treating coagulopathy in patients with severe burns. However, robust evidence for this idea …
[HTML][HTML] Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study
T Tagami, H Matsui, Y Moroe… - Annals of …, 2017 - annalsofintensivecare.springeropen …
Previous studies have suggested that antithrombin may be beneficial for treating
coagulopathy in patients with severe burns. However, robust evidence for this idea is …
coagulopathy in patients with severe burns. However, robust evidence for this idea is …
[引用][C] Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an observational nationwide study
T Tagami, H Matsui, Y Moroe, R Fukuda… - Annals of Intensive …, 2017 - cir.nii.ac.jp
Antithrombin use and 28-day in-hospital mortality among severe-burn patients: an
observational nationwide study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
observational nationwide study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …